Quick Answer
Opus Genetics, Inc. reported Shares Outstanding of 69.89 million shares for fiscal year 2025.
Opus Genetics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 69.89M | +121.4% |
| 2024 | 31.57M | +31.7% |
| 2023 | 23.98M | +14.9% |
| 2022 | 20.86M | +10.7% |
| 2021 | 18.85M | +73.2% |
| 2020 | 10.88M | +281.5% |
| 2019 | 2.85M | -8.7% |
| 2018 | 3.12M | -90.2% |
| 2017 | 31.73M | +33.7% |
| 2016 | 23.74M | -88.0% |
| 2015 | 197.41M | +10.7% |
| 2014 | 178.25M | +21.5% |
| 2013 | 146.72M | +22.8% |
| 2012 | 119.43M | +25.3% |
| 2011 | 95.35M | +13.3% |
| 2010 | 84.16M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 64.54M | +146.4% | +7.7% |
| June 30, 2025 | 59.91M | +130.6% | +31.7% |
| March 31, 2025 | 45.48M | +81.3% | +44.1% |
| December 31, 2024 | 31.57M | +31.7% | +20.5% |
| September 30, 2024 | 26.20M | +15.9% | +0.8% |
| June 30, 2024 | 25.98M | +23.8% | +3.6% |
| March 31, 2024 | 25.09M | +19.8% | +4.6% |
| December 31, 2023 | 23.98M | +14.9% | +6.0% |
- Opus Genetics, Inc. showed an increase of +121.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Opus Genetics, Inc.’s shares outstanding has declined by 17.0% (from 84.16 million shares to 69.89 million shares).
- The most recent figure is from Opus Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: